No abstract available
Publication types
-
Case Reports
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antibodies, Monoclonal, Humanized / therapeutic use*
-
Atypical Hemolytic Uremic Syndrome
-
Complement C5 / antagonists & inhibitors*
-
Complement Factor H / genetics
-
Complement Inactivating Agents / therapeutic use
-
Female
-
Hemolytic-Uremic Syndrome / genetics
-
Hemolytic-Uremic Syndrome / immunology
-
Hemolytic-Uremic Syndrome / prevention & control*
-
Humans
-
Kidney Failure, Chronic / etiology
-
Kidney Failure, Chronic / surgery
-
Kidney Transplantation* / adverse effects
-
Kidney Transplantation* / immunology
-
Living Donors
-
Mutation, Missense
-
Young Adult
Substances
-
Antibodies, Monoclonal, Humanized
-
CFH protein, human
-
Complement C5
-
Complement Inactivating Agents
-
Complement Factor H
-
eculizumab